Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 1.89
MGLN's Cash to Debt is ranked higher than
94% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.50 vs. MGLN: 1.89 )
MGLN' s 10-Year Cash to Debt Range
Min: 0.02   Max: 27173.79
Current: 1.89

0.02
27173.79
Equity to Asset 0.55
MGLN's Equity to Asset is ranked higher than
94% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.37 vs. MGLN: 0.55 )
MGLN' s 10-Year Equity to Asset Range
Min: -0.59   Max: 0.68
Current: 0.55

-0.59
0.68
Interest Coverage 55.40
MGLN's Interest Coverage is ranked higher than
93% of the 30 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.28 vs. MGLN: 55.40 )
MGLN' s 10-Year Interest Coverage Range
Min: 2.26   Max: 99.13
Current: 55.4

2.26
99.13
F-Score: 5
Z-Score: 4.21
M-Score: -2.04
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 3.06
MGLN's Operating margin (%) is ranked higher than
77% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.21 vs. MGLN: 3.06 )
MGLN' s 10-Year Operating margin (%) Range
Min: 0.13   Max: 9.77
Current: 3.06

0.13
9.77
Net-margin (%) 2.02
MGLN's Net-margin (%) is ranked higher than
83% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.36 vs. MGLN: 2.02 )
MGLN' s 10-Year Net-margin (%) Range
Min: -41.59   Max: 29.9
Current: 2.02

-41.59
29.9
ROE (%) 6.62
MGLN's ROE (%) is ranked higher than
71% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.54 vs. MGLN: 6.62 )
MGLN' s 10-Year ROE (%) Range
Min: -40.48   Max: 30.79
Current: 6.62

-40.48
30.79
ROA (%) 4.17
MGLN's ROA (%) is ranked higher than
89% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.04 vs. MGLN: 4.17 )
MGLN' s 10-Year ROA (%) Range
Min: -54.6   Max: 39.44
Current: 4.17

-54.6
39.44
ROC (Joel Greenblatt) (%) 42.82
MGLN's ROC (Joel Greenblatt) (%) is ranked higher than
71% of the 34 Companies
in the Global Health Care Plans industry.

( Industry Median: 137.23 vs. MGLN: 42.82 )
MGLN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 21.7   Max: 180.68
Current: 42.82

21.7
180.68
Revenue Growth (%) 14.10
MGLN's Revenue Growth (%) is ranked higher than
77% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.70 vs. MGLN: 14.10 )
MGLN' s 10-Year Revenue Growth (%) Range
Min: -40.3   Max: 64.6
Current: 14.1

-40.3
64.6
EBITDA Growth (%) 2.30
MGLN's EBITDA Growth (%) is ranked higher than
59% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.60 vs. MGLN: 2.30 )
MGLN' s 10-Year EBITDA Growth (%) Range
Min: -39.8   Max: 83.4
Current: 2.3

-39.8
83.4
EPS Growth (%) 4.00
MGLN's EPS Growth (%) is ranked higher than
68% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. MGLN: 4.00 )
MGLN' s 10-Year EPS Growth (%) Range
Min: -47.7   Max: 150.6
Current: 4

-47.7
150.6
» MGLN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

MGLN Guru Trades in Q3 2013

Paul Tudor Jones 6,500 sh (New)
Joel Greenblatt 3,820 sh (New)
Chuck Royce 1,300,416 sh (+0.28%)
Jim Simons 919,499 sh (-6.41%)
RS Investment Management 685,536 sh (-37.93%)
Steven Cohen 32,391 sh (-67.04%)
» More
Q4 2013

MGLN Guru Trades in Q4 2013

Paul Tudor Jones 16,582 sh (+155.11%)
Jim Simons 1,047,499 sh (+13.92%)
RS Investment Management 762,081 sh (+11.17%)
Joel Greenblatt 3,795 sh (-0.65%)
Chuck Royce 1,159,648 sh (-10.82%)
Steven Cohen 6,472 sh (-80.02%)
» More
Q1 2014

MGLN Guru Trades in Q1 2014

David Dreman 731 sh (New)
Jim Simons 1,259,499 sh (+20.24%)
RS Investment Management 827,082 sh (+8.53%)
Chuck Royce 1,159,648 sh (unchged)
Joel Greenblatt Sold Out
Paul Tudor Jones 14,028 sh (-15.4%)
Steven Cohen 4,228 sh (-34.67%)
» More
Q2 2014

MGLN Guru Trades in Q2 2014

David Dreman 999 sh (+36.66%)
RS Investment Management 1,013,097 sh (+22.49%)
Jim Simons 1,392,699 sh (+10.58%)
Paul Tudor Jones 13,789 sh (-1.7%)
Chuck Royce 403,406 sh (-65.21%)
» More
» Details

Insider Trades

Latest Guru Trades with MGLN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
David Dreman 2014-06-30 Add 36.66%$54.77 - $63.06 $ 60.052%999
Joel Greenblatt 2014-03-31 Sold Out 0.01%$58.22 - $61.14 $ 60.051%0
David Dreman 2014-03-31 New Buy$58.22 - $61.14 $ 60.051%731
Joel Greenblatt 2013-09-30 New Buy0.01%$55.69 - $59.97 $ 60.054%3820
Joel Greenblatt 2013-03-31 Sold Out 0.01%$47.45 - $54.23 $ 60.0517%0
Joel Greenblatt 2012-12-31 Reduce -53.6%0.02%$47.48 - $53.52 $ 60.0519%4119
Joel Greenblatt 2012-09-30 Reduce -86.65%0.19%$44.98 - $55.89 $ 60.0522%8878
Joel Greenblatt 2012-06-30 Add 22.82%0.04%$40.78 - $49.85 $ 60.0536%66503
Joel Greenblatt 2012-03-31 Add 73.43%0.1%$46.3 - $50.15 $ 60.0532%54148
Joel Greenblatt 2011-09-30 Add 43.04%0.06%$41.85 - $56.13 $ 60.0521%27164
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 21.80
MGLN's P/E(ttm) is ranked higher than
84% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.40 vs. MGLN: 21.80 )
MGLN' s 10-Year P/E(ttm) Range
Min: 3.33   Max: 22.89
Current: 21.8

3.33
22.89
P/B 1.45
MGLN's P/B is ranked higher than
84% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.03 vs. MGLN: 1.45 )
MGLN' s 10-Year P/B Range
Min: 1.13   Max: 2.96
Current: 1.45

1.13
2.96
P/S 0.44
MGLN's P/S is ranked higher than
82% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.51 vs. MGLN: 0.44 )
MGLN' s 10-Year P/S Range
Min: 0.39   Max: 1.12
Current: 0.44

0.39
1.12
PFCF 12.51
MGLN's PFCF is ranked higher than
87% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.79 vs. MGLN: 12.51 )
MGLN' s 10-Year PFCF Range
Min: 4.16   Max: 26.28
Current: 12.51

4.16
26.28
EV-to-EBIT 12.11
MGLN's EV-to-EBIT is ranked higher than
76% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.06 vs. MGLN: 12.11 )
MGLN' s 10-Year EV-to-EBIT Range
Min: 3.7   Max: 12.8
Current: 12.11

3.7
12.8
PEG 2.51
MGLN's PEG is ranked higher than
84% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.11 vs. MGLN: 2.51 )
MGLN' s 10-Year PEG Range
Min: 0.56   Max: 5.64
Current: 2.51

0.56
5.64
Shiller P/E 14.32
MGLN's Shiller P/E is ranked higher than
97% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 33.96 vs. MGLN: 14.32 )
MGLN' s 10-Year Shiller P/E Range
Min: 7.36   Max: 17.5
Current: 14.32

7.36
17.5
Current Ratio 2.10
MGLN's Current Ratio is ranked higher than
93% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.78 vs. MGLN: 2.10 )
MGLN' s 10-Year Current Ratio Range
Min: 0.23   Max: 2.42
Current: 2.1

0.23
2.42
Quick Ratio 2.03
MGLN's Quick Ratio is ranked higher than
93% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.78 vs. MGLN: 2.03 )
MGLN' s 10-Year Quick Ratio Range
Min: 0.23   Max: 2.42
Current: 2.03

0.23
2.42

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 3.79
MGLN's Price/Tangible Book is ranked higher than
84% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 9999.00 vs. MGLN: 3.79 )
MGLN' s 10-Year Price/Tangible Book Range
Min: 2.25   Max: 19.98
Current: 3.79

2.25
19.98
Price/DCF (Projected) 0.54
MGLN's Price/DCF (Projected) is ranked higher than
97% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.06 vs. MGLN: 0.54 )
MGLN' s 10-Year Price/DCF (Projected) Range
Min: 0.38   Max: 1.45
Current: 0.54

0.38
1.45
Price/Median PS Value 0.78
MGLN's Price/Median PS Value is ranked higher than
92% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.18 vs. MGLN: 0.78 )
MGLN' s 10-Year Price/Median PS Value Range
Min: 0.71   Max: 1.8
Current: 0.78

0.71
1.8
Price/Graham Number 1.96
MGLN's Price/Graham Number is ranked higher than
92% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 9999.00 vs. MGLN: 1.96 )
MGLN' s 10-Year Price/Graham Number Range
Min: 0.9   Max: 4.06
Current: 1.96

0.9
4.06
Earnings Yield (Greenblatt) 8.30
MGLN's Earnings Yield (Greenblatt) is ranked higher than
74% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.90 vs. MGLN: 8.30 )
MGLN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 7.8   Max: 27.3
Current: 8.3

7.8
27.3
Forward Rate of Return (Yacktman) 10.27
MGLN's Forward Rate of Return (Yacktman) is ranked higher than
76% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.52 vs. MGLN: 10.27 )
MGLN' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -5.7   Max: 26.3
Current: 10.27

-5.7
26.3

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:UNH, ESRX, WLP, HUM, AET » details
Traded in other countries:MAH1.Germany
Magellan Health Services, Inc., a Delaware corporation was incorporated in 1969. The Company provides specialty healthcare services. The Company's business is divided into six segments, based on the services it provides and/or the customers that it serves. Managed Behavioral Healthcare, two of the Company's segments are in the managed behavioral healthcare business. This line of business generally reflects the Company's coordination and management of the delivery of behavioral healthcare treatment services that are provided through its contracted network of third-party treatment providers, which includes psychiatrists, psychologists, other behavioral health professionals, psychiatric hospitals, general medical facilities with psychiatric beds, residential treatment centers and other treatment facilities. The treatment services provided through the Company's provider network include outpatient programs (such as counseling or therapy), intermediate care programs (such as intensive outpatient programs and partial hospitalization services), inpatient treatment and crisis intervention services. The managed behavioral healthcare business is managed based on the services provided and/or the customers served, through the following two segments: Commercial and Public Sector. The Radiology Benefits Management segment generally reflects the management of the delivery of diagnostic imaging services to ensure that such services are clinically appropriate and cost effective. The Company's radiology benefits management services currently are provided under contracts with health plans and insurance companies for some or all of their commercial, Medicaid and Medicare members. The Company also contracts with state and local governmental agencies for the provision of such services to Medicaid recipients. The Specialty Pharmaceutical Management segment generally reflects the management of specialty drugs used in the treatment of cancer, multiple sclerosis, hemophilia, infertility, rheumatoid arthritis, chronic forms of hepatitis and other diseases. Specialty pharmaceutical drugs represent high-cost injectible, infused, oral, or inhaled drugs often with sensitive handling or storage needs. The Medicaid Administration segment generally reflects integrated clinical management services provided to the public sector to manage Medicaid, pharmacy, mental health and long-term care programs. The Company's Medicaid Administration services include the management of pharmacy benefits administration ('PBA'), medical management information services and fiscal agent services ('FAS'), and health care management services ('HCM'). This segment of the Company is comprised mainly of operational support functions such as sales and marketing and information technology, as well as corporate support functions such as executive, finance, human resources and legal. The Company's business is competitive. The Company competes with other healthcare organizations as well as with
» More Articles for MGLN

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight: CLR, TRUE, ARP, MGLN, CLMS May 26 2014 
Largest Insider Buys of the Week May 23 2014 
Weekly CFO Sells Highlight: PFPT, VRSK, FET, DSW, MGLN Jul 14 2013 
CFO of Magellan Health Services Inc. Jonathan N. Rubin Sold 27,950 Shares Jul 11 2013 
comment on MGLN May 21 2013 
comment on MGLN May 17 2013 
comment on MGLN May 17 2013 
comment on MGLN Apr 14 2013 
Magellan Health Services Inc. (MGLN) CEO, National Imaging Assoc. Tina Blasi sells 18,220 Shares Mar 08 2011 
Magellan Health Services Inc. Reports Operating Results (10-K) Feb 25 2011 

More From Our Partners
Magellan Health: Analysis Of Earnings Beat Oct 30 2014 - SEEKINGALPHA

More From Other Websites
MAGELLAN HEALTH INC Financials Oct 30 2014
Magellan Health to Participate in Upcoming Barclays Select Series Conference Oct 28 2014
Magellan Health Inc (MGLN) Upgraded From Hold to Buy Oct 28 2014
Will Growth Measures Reflect on Aetna (AET) Q3 Earnings? Oct 27 2014
Magellan Health Q3 Earnings Beat; Revises Guidance Oct 27 2014
Magellan Health Opens Toll-Free Number Following Shooting at Marysville-Pilchuck High School in... Oct 24 2014
MAGELLAN HEALTH INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events,... Oct 24 2014
Magellan Health Inc Earnings Call scheduled for 10:00 am ET today Oct 24 2014
Morning MoneyBeat: Amid Roller Coaster, Investors Remain Upbeat Oct 24 2014
Q3 2014 Magellan Health Inc Earnings Release - Before Market Open Oct 24 2014
Magellan Health tops 3Q profit forecasts Oct 24 2014
Magellan Health tops 3Q profit forecasts Oct 24 2014
Magellan Health Reports Third Quarter 2014 Financial Results Oct 24 2014
Magellan Health Announces Third Quarter 2014 Earnings Conference Call Oct 23 2014
Why Magellan Health (MGLN) Might Surprise This Earnings Season Oct 23 2014
Magellan Health Selects HMS for National Fraud, Waste, and Abuse Services and Coordination of... Oct 21 2014
Magellan Health Selects HMS for National Fraud, Waste, and Abuse Services and Coordination of... Oct 21 2014
Magellan Health’s Pharmacy Business Obtains URAC Accreditation Sep 29 2014
Magellan Health Headquarters Opens in Scottsdale, Arizona Sep 15 2014
Magellan Health Announces Third Quarter 2014 Earnings Conference Call Sep 12 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK